Tech Company Financing Transactions
DC Devices Funding Round
On 7/1/2014, DC Devices landed $34 million in Series D funding from General Catalyst Partners, Lumira Capital and Third Rock Ventures.
Transaction Overview
Company Name
Announced On
7/1/2014
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series D
Investors
General Catalyst Partners (Hemant Taneja)
Lumira Capital (Gerry Brunk)
Third Rock Ventures (Mark Levin)
Proceeds Purpose
Funds will be used to complete clinical evaluation of the world's first transcatheter device for the treatment of diastolic heart failure (DHF), a $5 billion global market opportunity.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1 Highwood Dr. 300
Tewksbury, MA 01876
USA
Tewksbury, MA 01876
USA
Phone
Website
Email Address
Not Recorded
Overview
DC Devices is developing the first trans-catheter device for diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Fazio
Chief Medical Officer
Jan Komtebedde
Vice President
Anne Kulis
VP - R & D
Ed McNamara
Browse more venture capital transactions:
Prev: 7/1/2014: posto7 venture capital transaction
Next: 7/1/2014: Partnered venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs